Molecular insights for the biological interactions between polyethylene glycol and cells

Pasut, 2012, State of the art in PEGylation: the great versatility achieved after forty years of research, J. Control. Release, 161, 461, 10.1016/j.jconrel.2011.10.037 Veronese, 2005, PEGylation, successful approach to drug delivery, Drug. Discov. Today, 10, 1451, 10.1016/S1359-6446(05)03575-0 Veronese, 2008, Peptide and protein PEGylation III: advances in chemistry and clinical applications, Adv. Drug Deliv. Rev., 60, 1, 10.1016/j.addr.2007.08.003 Pasut, 2009, PEG conjugates in clinical development or use as anticancer agents: an overview, Adv. Drug Deliv. Rev., 61, 1177, 10.1016/j.addr.2009.02.010 Otsuka, 2012, PEGylated nanoparticles for biological and pharmaceutical applications, Adv. Drug Deliv. Rev., 64, 246, 10.1016/j.addr.2012.09.022 Schmidt-Wolf, 2003, Non-viral and hybrid vectors in human gene therapy: an update, Trends Mol. Med., 9, 67, 10.1016/S1471-4914(03)00005-4 Santoro, 2016, Poly(lactic acid) nanofibrous scaffolds for tissue engineering, Adv. Drug Deliv. Rev., 107, 206, 10.1016/j.addr.2016.04.019 Weissleder, 2014, Imaging macrophages with nanoparticles, Nat. Mater., 13, 125, 10.1038/nmat3780 Ashbaugh, 2016, Polymeric nanofiber coating with tunable combinatorial antibiotic delivery prevents biofilm-associated infection in vivo, Proc. Natl. Acad. Sci. U. S. A., 113, 6919, 10.1073/pnas.1613722113 Markoysky, 2012, Administration, distribution, metabolism and elimination of polymer therapeutics, J. Control. Release, 161, 446, 10.1016/j.jconrel.2011.12.021 Webber, 2016, Supramolecular biomaterials, Nat. Mater., 15, 13, 10.1038/nmat4474 Ramakrishna, 2001, Biomedical applications of polymer-composite materials: a review, Compos. Sci. Technol., 61, 1189, 10.1016/S0266-3538(00)00241-4 Williams, 2008, On the mechanisms of biocompatibility, Biomaterials, 29, 2941, 10.1016/j.biomaterials.2008.04.023 Fruijtier-Polloth, 2005, Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products, Toxicology, 214, 1, 10.1016/j.tox.2005.06.001 Knop, 2010, Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives, Angew. Chem. Int. Ed., 49, 6288, 10.1002/anie.200902672 Webster, 2007, PEGylated proteins: evaluation of their safety in the absence of definitive metabolism studies, Drug Metabol. Dispos. Biol. Fate Chem., 35, 9, 10.1124/dmd.106.012419 Hamad, 2008, Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process, Mol. Immunol., 46, 225, 10.1016/j.molimm.2008.08.276 Schellekens, 2013, The immunogenicity of polyethylene glycol: facts and fiction, Pharm. Res., 30, 1729, 10.1007/s11095-013-1067-7 Armstrong, 2007, Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients, Cancer, 110, 103, 10.1002/cncr.22739 Green, 2016, Mimicking biological functionality with polymers for biomedical applications, Nature, 540, 386, 10.1038/nature21005 Hunter, 2006, Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity, Adv. Drug Deliv. Rev., 58, 1523, 10.1016/j.addr.2006.09.008 Tanaka, 2015, Design of biocompatible and biodegradable polymers based on intermediate water concept, Polym. J., 47, 114, 10.1038/pj.2014.129 Mizushima, 2010, Methods in mammalian autophagy research, Cell, 140, 313, 10.1016/j.cell.2010.01.028 Klionsky, 2016, Guidelines for the use and interpretation of assays for monitoring autophagy, Autophagy, 12, 1, 10.1080/15548627.2015.1100356 Jin, 2013, Metabolic profiling reveals disorder of carbohydrate metabolism in mouse fibroblast cells induced by titanium dioxide nanoparticles, J. Appl. Toxicol., 33, 1442, 10.1002/jat.2808 Zhang, 2016, Metabonomics approach to assessing the metabolism variation and endoexogenous metabolic interaction of ginsenosides in cold stress rats, J. Proteome Res., 15, 1842, 10.1021/acs.jproteome.6b00015 Aragon, 1976, Fluorescence correlation spectroscopy as a probe of molecular-dynamics, J. Chem. Phys., 64, 1791, 10.1063/1.432357 Dong, 2014, Assessing the blinking state of fluorescent quantum dots in free solution by combining fluorescence correlation spectroscopy with ensemble spectroscopic methods, Langmuir, 30, 12969, 10.1021/la503055v Ruan, 2012, Highly sensitive method for assay of drug-induced apoptosis using fluorescence correlation spectroscopy, Anal. Chem., 84, 7350, 10.1021/ac301654g Tanida, 2005, Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy, Autophagy, 1, 84, 10.4161/auto.1.2.1697 Mizushima, 2007, Protein turnover via autophagy: implications for metabolism, Annu. Rev. Nutr., 27, 19, 10.1146/annurev.nutr.27.061406.093749 Green, 2014, To be or not to be? How selective autophagy and cell death govern cell fate, Cell, 157, 65, 10.1016/j.cell.2014.02.049 Streeter, 2016, LC3-II tagging and western blotting for monitoring autophagic activity in mammalian cells, Methods Mol. Biol., 1303, 161, 10.1007/978-1-4939-2627-5_8 Lamb, 2013, The autophagosome: origins unknown, biogenesis complex, Nature reviews, Mol. Cell Biol., 14, 759 Petibone, 2017, Autophagy function and its relationship to pathology, clinical applications, drug metabolism and toxicity, J. Appl. Toxicol., 37, 23, 10.1002/jat.3393 Maiuri, 2007, Self-eating and self-killing: crosstalk between autophagy and apoptosis, Nat. Rev. Mol. Cel. Biol., 8, 741, 10.1038/nrm2239 Kimura, 2013, Chloroquine in cancer therapy: a double-edged sword of autophagy, Cancer Res., 73, 3, 10.1158/0008-5472.CAN-12-2464 Ichimura, 2010, Selective degradation of p62 by autophagy, Semin. Immunopathol., 32, 431, 10.1007/s00281-010-0220-1 Eng, 2010, Ammonia derived from glutaminolysis is a diffusible regulator of autophagy, Sci. Signal., 3, ra31, 10.1126/scisignal.2000911 Seglen, 1982, 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes, Proc. Natl. Acad. Sci. U. S. A., 79, 1889, 10.1073/pnas.79.6.1889 Keun, 2006, Metabonomic modeling of drug toxicity, Pharmacol. Ther., 109, 92, 10.1016/j.pharmthera.2005.06.008 Nicholson, 2008, Systems biology: metabonomics, Nature, 455, 1054, 10.1038/4551054a Schnackenberg, 2012, Metabolomics techniques in nanotoxicology studies, Methods Mol. Biol., 926, 141, 10.1007/978-1-62703-002-1_10 Green, 2014, Metabolic control of cell death, Science, 345, 10.1126/science.1250256 Vander Heiden, 2009, Understanding the warburg effect: the metabolic requirements of cell proliferation, Science, 324, 1029, 10.1126/science.1160809 Kroemer, 2010, Autophagy and the integrated stress response, Mol. Cell, 40, 280, 10.1016/j.molcel.2010.09.023 Mazure, 2010, Hypoxia-induced autophagy: cell death or cell survival?, Curr. Opin. Cell. Biol., 22, 177, 10.1016/j.ceb.2009.11.015 Majmundar, 2010, Hypoxia-inducible factors and the response to hypoxic stress, Mol. Cell., 40, 294, 10.1016/j.molcel.2010.09.022 Bellot, 2009, Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains, Mol. Cell. Biol., 29, 2570, 10.1128/MCB.00166-09 Azad, 2008, Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3, Autophagy, 4, 195, 10.4161/auto.5278 Cheong, 2011, Ammonia-induced autophagy is independent of ULK1/ULK2 kinases, Proc. Natl. Acad. Sci. U. S. A., 108, 11121, 10.1073/pnas.1107969108 Rabinowitz, 2010, Autophagy and metabolism, Science, 330, 1344, 10.1126/science.1193497 Levine, 2008, Autophagy in the pathogenesis of disease, Cell, 132, 27, 10.1016/j.cell.2007.12.018 Loos, 2013, The variability of autophagy and cell death susceptibility: unanswered questions, Autophagy, 9, 1270, 10.4161/auto.25560 Seglen, 1976, Ammonia inhibition of protein degradation in isolated rat hepatocytes: quantitative ultrastructural alterations in the lysosomal system, Exp. Cell Res., 100, 276, 10.1016/0014-4827(76)90148-8 Hopgood, 1977, Inhibition of protein degradation in isolated rat hepatocytes, Biochem. J., 164, 399, 10.1042/bj1640399 Seglen, 1979, Inhibition of the lysosomal pathway of protein degradation in isolated rat hepatocytes by ammonia, methylamine, chloroquine and leupeptin, Eur. J. Biochem., 95, 215, 10.1111/j.1432-1033.1979.tb12956.x Wu, 2009, Amino acids: metabolism, functions, and nutrition, Amino Acids, 37, 1, 10.1007/s00726-009-0269-0 Broer, 2017, Amino acid homeostasis and signalling in mammalian cells and organisms, Biochem. J., 474, 1935, 10.1042/BCJ20160822 Rudmann, 2013, High molecular weight polyethylene glycol cellular distribution and PEG-associated cytoplasmic vacuolation is molecular weight dependent and does not require conjugation to proteins, Toxicol. Pathol., 41, 970, 10.1177/0192623312474726 Kronenberg, 2013, Current challenges and opportunities in nonclinical safety testing of biologics, Drug. Discov. Today, 18, 1138, 10.1016/j.drudis.2013.08.003 Baumann, 2014, Pharmacokinetics, metabolism and distribution of PEGs and PEGylated proteins: quo vadis?, Drug. Discov. Today, 19, 1623, 10.1016/j.drudis.2014.06.002 Ramot, 2016, Biocompatibility and safety of PLA and its copolymers, Adv. Drug Deliv. Rev., 107, 153, 10.1016/j.addr.2016.03.012 Serrano, 2004, In vitro biocompatibility assessment of poly(e-caprolactone) films usingL929 mouse fibroblasts, Biomaterials, 25, 5603, 10.1016/j.biomaterials.2004.01.037